000 01369 a2200397 4500
005 20250517214519.0
264 0 _c20181115
008 201811s 0 0 chi d
022 _a0376-2491
024 7 _a10.3760/cma.j.issn.0376-2491.2018.16.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBian, L
245 0 0 _a[Study of bioequiavailability of paclitaxel for Injection (Albumin Bound) and abraxane and the efficacy of extension treatments in patients with metastatic breast cancer].
_h[electronic resource]
260 _bZhonghua yi xue za zhi
_cApr 2018
300 _a1236-1241 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAlbumin-Bound Paclitaxel
650 0 4 _aAlbumins
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
650 0 4 _aBreast Neoplasms
650 0 4 _aHumans
650 0 4 _aPaclitaxel
650 0 4 _aTreatment Outcome
700 1 _aGeng, C Z
700 1 _aOuyang, Q C
700 1 _aHu, X C
700 1 _aPeng, Y Y
700 1 _aXiao, J Y
700 1 _aWang, M X
700 1 _aYang, N
700 1 _aYuan, J
700 1 _aWang, Y M
700 1 _aJiang, Z F
773 0 _tZhonghua yi xue za zhi
_gvol. 98
_gno. 16
_gp. 1236-1241
856 4 0 _uhttps://doi.org/10.3760/cma.j.issn.0376-2491.2018.16.010
_zAvailable from publisher's website
999 _c28377596
_d28377596